Prof. Tobias Engel is a Lecturer in Physiology & Medical Physics at RCSI, with expertise in neurobiology and epileptogenesis. His research addresses purinergic signalling (especially P2X7 receptors) and hyperexcitability in neurological disorders such as traumatic brain injury (TBI) and epilepsy, seeking to uncover mechanisms of brain damage and novel interventions.
Prof. Tobias Engel is a Lecturer in Physiology & Medical Physics at RCSI, with expertise in neurobiology and epileptogenesis. His research addresses purinergic signalling (especially P2X7 receptors) and hyperexcitability in neurological disorders such as traumatic brain injury (TBI) and epilepsy, seeking to uncover mechanisms of brain damage and novel interventions.
Last Updated:
Research Areas:
Research Programmes
Related News

Innovation Training for ARC Hub for Therapeutics Translational Researchers
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...

New €31.6 million ARC Hub for Therapeutics to turn breakthrough Irish research into therapies and companies
On December 3rd, 2025, we marked a major milestone for Ireland’s therapeutics ecosystem. The launch of the ARC Hub for Therapeutics was an energising and inspiring day, bringing together a brilliant community of academics, investors, funders, policymakers, and...
